ELOXX PHARMACEUTICALS, INC. AMENDMENT TO STOCK OPTION AGREEMENTStock Option Agreement • October 17th, 2024 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment to Stock Option Agreement (the “Amendment”) is made as of October 16, 2024 between the undersigned Participant (“Participant”) and Eloxx Pharmaceuticals, Inc. (the “Company”).
